Surrozen (SRZN) Competitors $13.91 -0.13 (-0.93%) As of 11:13 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRZN vs. EOLS, KMDA, YMAB, DSGN, FDMT, AURA, CGC, BNTC, LXEO, and DMACShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include Evolus (EOLS), Kamada (KMDA), Y-mAbs Therapeutics (YMAB), Design Therapeutics (DSGN), 4D Molecular Therapeutics (FDMT), Aura Biosciences (AURA), Canopy Growth (CGC), Benitec Biopharma (BNTC), Lexeo Therapeutics (LXEO), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. Surrozen vs. Its Competitors Evolus Kamada Y-mAbs Therapeutics Design Therapeutics 4D Molecular Therapeutics Aura Biosciences Canopy Growth Benitec Biopharma Lexeo Therapeutics DiaMedica Therapeutics Evolus (NASDAQ:EOLS) and Surrozen (NASDAQ:SRZN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Which has more volatility & risk, EOLS or SRZN? Evolus has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Comparatively, Surrozen has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Does the media refer more to EOLS or SRZN? In the previous week, Evolus had 2 more articles in the media than Surrozen. MarketBeat recorded 5 mentions for Evolus and 3 mentions for Surrozen. Evolus' average media sentiment score of 0.32 beat Surrozen's score of 0.00 indicating that Evolus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolus 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Surrozen 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, EOLS or SRZN? Evolus has higher revenue and earnings than Surrozen. Evolus is trading at a lower price-to-earnings ratio than Surrozen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvolus$266.27M1.50-$50.42M-$0.98-6.32Surrozen$12.62M9.45-$63.56M-$14.42-0.96 Do analysts recommend EOLS or SRZN? Evolus presently has a consensus price target of $21.25, suggesting a potential upside of 243.02%. Surrozen has a consensus price target of $38.50, suggesting a potential upside of 176.78%. Given Evolus' stronger consensus rating and higher probable upside, analysts clearly believe Evolus is more favorable than Surrozen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evolus 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40Surrozen 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is EOLS or SRZN more profitable? Evolus has a net margin of -22.31% compared to Surrozen's net margin of -274.42%. Surrozen's return on equity of -545.43% beat Evolus' return on equity.Company Net Margins Return on Equity Return on Assets Evolus-22.31% -759.04% -24.63% Surrozen -274.42%-545.43%-64.40% Do institutionals and insiders hold more shares of EOLS or SRZN? 90.7% of Evolus shares are owned by institutional investors. Comparatively, 66.6% of Surrozen shares are owned by institutional investors. 5.9% of Evolus shares are owned by insiders. Comparatively, 45.2% of Surrozen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryEvolus beats Surrozen on 12 of the 16 factors compared between the two stocks. Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRZN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$119.21M$2.65B$9.08B$10.58BDividend YieldN/A56.71%5.69%4.71%P/E Ratio-0.9623.4386.1627.45Price / Sales9.45583.66539.92202.26Price / CashN/A173.2337.9261.55Price / Book-2.125.5913.056.77Net Income-$63.56M$32.78M$3.30B$275.88M7 Day Performance1.02%5.84%4.55%2.63%1 Month Performance18.89%13.22%9.73%9.10%1 Year Performance17.78%2.13%85.10%35.69% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen1.7628 of 5 stars$13.91-0.9%$38.50+176.8%+25.7%$119.21M$12.62M-0.9680News CoverageAnalyst ForecastEOLSEvolus3.9728 of 5 stars$6.14flat$21.25+246.1%-62.4%$397.17M$277.94M-6.27170Positive NewsAnalyst RevisionKMDAKamada4.5358 of 5 stars$6.94+1.0%$13.00+87.3%+30.0%$395.06M$160.95M20.41360Positive NewsAnalyst ForecastAnalyst RevisionYMABY-mAbs Therapeutics1.7332 of 5 stars$8.61flat$9.62+11.8%N/A$391.24M$87.68M-17.22150DSGNDesign Therapeutics0.05 of 5 stars$7.53+9.9%N/A+41.1%$390.10MN/A-6.7240News CoverageAnalyst ForecastFDMT4D Molecular Therapeutics2.4445 of 5 stars$8.69+4.1%$30.40+249.8%+3.0%$389.97M$40K-2.46120Analyst ForecastAURAAura Biosciences2.2095 of 5 stars$6.18+0.2%$22.00+256.0%-27.9%$383.28MN/A-3.1550News CoverageAnalyst ForecastCGCCanopy Growth0.6575 of 5 stars$1.46-7.0%N/A-62.6%$376.56M$225.65M-0.483,150Analyst ForecastGap UpBNTCBenitec Biopharma2.0258 of 5 stars$14.03+0.3%$24.80+76.8%+49.0%$367.24MN/A-9.5420News CoverageAnalyst DowngradeLXEOLexeo Therapeutics3.0585 of 5 stars$6.64-0.3%$15.33+130.9%-8.2%$359.65M$650K-2.0458News CoverageAnalyst ForecastDMACDiaMedica Therapeutics2.1967 of 5 stars$6.87-0.6%$12.33+79.5%+49.7%$357.17MN/A-9.9620Analyst Forecast Related Companies and Tools Related Companies EOLS Competitors KMDA Competitors YMAB Competitors DSGN Competitors FDMT Competitors AURA Competitors CGC Competitors BNTC Competitors LXEO Competitors DMAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRZN) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
